Dr. David JablonsFocus: Pleural Mesothelioma
University of California San Francisco
1600 Divisadero St.
San Francisco, CA
Dr. David Jablons is an Ada Distinguished Professor in Thoracic Oncology at the University of California San Francisco (UCSF) Medical Center. He has trained alongside many nationally recognized oncologists and has years of experience with helping patients combat lung cancer and mesothelioma.
About Dr. Jablons
Dr. David M. Jablons is a Thoracic Surgeon at UCSF. He serves as a distinguished professor and as the Chief of General Thoracic Surgery.
Not only does Dr. Jablons carry the title as an Ada Distinguished Professor in Thoracic Oncology, but he is also recognized as a Nan T. McEvoy Distinguished Professor of Thoracic Surgical Oncology.
Before coming to the University of California San Francisco, Dr. Jablons was mentored by mesothelioma specialist David Sugarbaker.
Dr. Jablons also served our country in the military. He was a Navy commander and the Chief of Thoracic Surgery at the Oakland Naval Hospital.
Even though Dr. Jablons’ main mission is to treat and cure lung cancer, he also has a clinical interest and expertise in treating patients diagnosed with mesothelioma. He works alongside his team in the Thoracic Oncology Lab at UCSF to pioneer ways to combat the disease.
Medical Degree and Residency
MD Albany Medical College in Albany, NY (1984). Dr. David Jablons has completed a series of residencies in surgery. He completed residencies in General Surgery at Oak Knoll Naval Hospital in Oakland, CA (1984-1985) and at Tufts Medical Center in Boston, MA (1985-1986 and 1989-1991). Dr. Jablons also completed a residency in Cardiothoracic Surgery at Weill Cornell Medicine in New York, NY (1991-1993).
Dr. Jablons is a professor and the Chief of General Thoracic Surgery at the University of California San Francisco. He is also the Program Leader of Thoracic Oncology Program.
Dr. Jablons’ Accomplishments
- Co-founder of the UCSF Thoracic Oncology Conference
- Helped establish the China Clinical Trials Consortium
- Inducted into the American Surgical Society
- Listed on the U.S. News “America’s Top Doctors” list
- Received the Surgical Resident Teaching Award from UCSF in 1999 and 2001
- Involved in research dedicated to finding cures for lung cancer and mesothelioma
Get Connected to Dr. David Jablons
Why Choose Dr. David Jablons?
- He performs invasive surgeries that result in quicker recovery.
- Patients under his care experience individualized care.
- He has helped many mesothelioma patients reach remission.
Meet Dr. David Jablons
Treating Mesothelioma at UCSF
Since being recruited at UCSF, Dr. Jablons has helped develop the Thoracic Oncology Lab.
The Thoracic Surgery team at UCSF is always investigating new ways to treat mesothelioma and lung cancer patients. For example, Dr. Jablons and his team have been investigating the Wnt pathway of malignant mesothelioma.
One form of treatment that the Thoracic Surgery team is recognized for is using video-assisted thoracoscopic surgery (VATS) to remove a patient’s tumors.
Patients that experience VATS typically have the following results:
- Less pain
- Decreased risk of infection
- Shorter hospital stays
- Quicker recovery
- Better responses to chemotherapy
Many mesothelioma patients may choose UCSF when it comes to seeking personalized treatment. Patients can also have a peace of mind because they are in the hands of highly trained surgeons. As a matter of fact, the thoracic surgeons at UCSF perform approximately 400 procedures annually.
The Thoracic Surgery Program is known for treating many stages of mesothelioma patients. In many circumstances, many of UCSF’s patients have been told they aren’t good surgical candidates by other institutes. In fact, many mesothelioma patients turn to UCSF for a second opinion.
For more information about Dr. Jablons and the Thoracic Surgery Program at UCSF, please contact Mesothelioma Guide’s patient advocate Jenna Campagna. You can reach her at 888-385-2024 extension 102 or at firstname.lastname@example.org.